ReviewPediatric rheumatology online journal2026
Spectrum of MEFV variants in 8,252 patients from Eastern and Southeastern Anatolia: a large single-center cohort study (2019-2026).
Review in Pediatric rheumatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFamilial Mediterranean Fever (FMF) is a monogenic autoinflammatory disorder caused by variants in MEFV. Although Türkiye carries a considerable FMF burden, large contemporary single-center genetic datasets from Eastern and Southeastern Anatolia are still limited. Because the frequency and distribution of MEFV variants differ across populations and regions, locally derived reference data remain important for clinical interpretation.
objectiveTo characterize the MEFV variant spectrum and genotype categories in a large single-center cohort representing Eastern and Southeastern Anatolia.
methodsWe performed a retrospective review of 8,252 consecutive referrals tested for recurrent MEFV common variants at a tertiary genetics laboratory between 2019 and 2026. Demographic variables and genotype results were retrieved from the laboratory information system. Results were grouped as wild-type (WT), monoallelic, or multi-allelic, and multi-allelic findings were further classified as homozygous, compound heterozygous, or complex multi-site configurations.
resultsThe median age was 17 years (mean 22.0 ± 16.9 years; range 0-84), and 53.8% of individuals were female. Genotype categories were distributed as follows: WT 60.4% (4,985/8,252), monoallelic 28.2% (2,327/8,252), and multi-allelic 11.4% (940/8,252), including homozygous 3.8% (311/8,252), compound heterozygous 6.9% (569/8,252), and complex multi-site 0.7% (60/8,252). The most frequent variants were M694V 14.5% (1,199/8,252), E148Q 14.0% (1,158/8,252), V726A 5.2% (426/8,252), and M680I (G > C) 4.1% (337/8,252). Exon 10 variants accounted for a substantial proportion of variant-positive findings, while E148Q was common but predominantly heterozygous. Variant rankings were broadly similar between females and males.
conclusionsThis study provides a large region-specific reference for MEFV variation in Eastern and Southeastern Anatolia. The predominance of M694V and other exon 10 variants, together with the high background frequency of E148Q, has direct relevance for pre-test counseling, targeted testing strategies, and interpretation of routine FMF results. Further work incorporating sequencing-based assays and standardized clinical follow-up will be necessary to refine genotype-phenotype relationships and improve variant interpretation in this high-burden setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.